Lifeboat Foundation

Perfect recall, computational wizardry and rapier wit: That’s the brain we all want, but how does one design such a brain? The real thing is comprised of ~80 billion neurons that coordinate with one another through tens of thousands of connections in the form of synapses. The human brain has no centralized processor, the way a standard laptop does.

Instead, many calculations are run in parallel, and outcomes are compared. While the operating principles of the human brain are not fully understood, existing mathematical algorithms can be used to rework deep learning principles into systems more like a human brain would. This brain-inspired computing paradigm—spiking neural networks (SNN)—provides a computing architecture well-aligned with the potential advantages of systems using both optical and electronic components.

In SNNs, information is processed in the form of spikes or action potentials, which are the electrical impulses that occur in real neurons when they fire. One of their key features is that they use asynchronous processing, meaning that spikes are processed as they occur in time, rather than being processed in a batch like in traditional neural networks. This allows SNNs to react quickly to changes in their inputs, and to perform certain types of computations more efficiently than traditional neural networks.

Apple is overtly teasing the start of “a new era” and the ability to “code new worlds” at WWDC this year, building anticipation around the widely expected announcement of its mixed-reality headset.

A tweet shared by Apple earlier today made the “new era” remark, seemingly leaning into the high expectations surrounding next week’s WWDC keynote. The launch of a major new device and operating system, something that has not occurred since the debut of the original Apple Watch in September 2014, would certainly seem to justify the start of a new era for the company.

Winsight is a leading B2B information services company focused on the food and beverage industry, providing insight and market intelligence to business leaders in every channel consumers buy food and beverage – convenience stores, grocery retailing, restaurants and noncommercial foodservice – through media, events, data products, advisory services, and trade shows.

Copyright © Winsight, LLC.

Generative AI can help businesses in many sectors increase efficiency and boost their bottom-lines, not just tech giants. A UBS report analyzes well-positioned firms.

The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study.

Terry Horgan, 27, of Montour Falls, New York, died last year during one of the first tests of a gene-editing treatment designed for one person. Some scientists wondered if the gene-editing tool CRISPR played a part in his death. The tool has transformed genetic research, sparked the development of dozens of experimental drugs, and won its inventors the Nobel Prize in 2020.

But researchers said the virus — one used to carry treatment into the body because it doesn’t usually make people sick — combined with his condition, triggered the problems that ultimately killed him.

Making things that think.

Published 49 mins ago.

The future of humanoid robots is being developed by a Texas company called Apptronik.

Is the Quantum for Bio Program Director, at Wellcome Leap (https://wellcomeleap.org/our-team/elicakyoseva/), a $40M +$10M program focused on identifying, developing, and demonstrating biology and healthcare applications that will benefit from the quantum computers expected to emerge in the next 3–5 years.

Wellcome Leap was established with $300 million in initial funding from the Wellcome Trust, the UK charitable foundation, to accelerate discovery and innovation for the benefit of human health, focusing on build bold, unconventional programs and fund them at scale—specifically programs that target global human health challenges, with the goal of achieving breakthrough scientific and technological solutions.

Continue reading “Dr. Elica Kyoseva, Ph.D. — Quantum for Bio Program Director — Wellcome Leap” »